Avenue Therapeutics Inc (ATXI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.3620 +0.0070 (+1.97%) 03/21/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.3620 unch (unch) 15:53 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2006 | |
| Operating Expenses | 21,816 | 11,421 | 2,377 | 0 | 0 |
| Operating Income | -21,816 | -11,421 | -2,377 | N/A | N/A |
| Interest Expense | 0 | 375 | 612 | 0 | 0 |
| Other Income | 268 | -462 | -188 | 0 | 0 |
| Pre-tax Income | -21,548 | -12,258 | -3,177 | 0 | 0 |
| Net Income Continuous | -21,548 | -12,258 | -3,177 | N/A | N/A |
| Net Income | $-21,548 | $-12,258 | $-3,177 | $0 | $N/A |
| EPS Basic Total Ops | -2,367.24 | -2,085.42 | -1,251.25 | N/A | N/A |
| EPS Basic Continuous Ops | -2,372.31 | -2,082.58 | -1,251.76 | N/A | N/A |
| EPS Diluted Total Ops | -2,367.24 | -2,085.42 | -1,251.25 | N/A | N/A |
| EPS Diluted Continuous Ops | -2,372.31 | -2,082.58 | -1,251.76 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -2,367.24 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-21,816 | $-11,247 | $-2,254 | $N/A | $N/A |